Tech Company Financing Transactions
HydRegen Funding Round
On 10/14/2026, HydRegen landed $8 million in Series A funding from Genoa Ventures, Clean Growth Fund and Oxford Technology and Innovations Fund.
Transaction Overview
Company Name
Announced On
10/14/2026
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Oxford, Undisclosed
UK
Oxford, Undisclosed
UK
Phone
Undisclosed
Website
Email Address
Overview
Our biotechnologies enable more sustainable chemical synthesis and manufacturing by replacing toxic, heavy-metal catalysts, operating under mild reaction conditions, minimising waste and operating in continuous flow. HydRegen is a spinout company from the Department of Chemistry (University of Oxford), commercialising a biotechnology from the group of Prof. Kylie Vincent.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Holly Reeve
Chief Scientific Officer
Sarah Cleary
Browse more venture capital transactions:
Prev: 10/14/2026: Picktrace venture capital transaction
Next: 10/14/2026: Tamr venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs